AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2025
Feb 25, 2025
32559_dirs_2025-02-24_10963b79-404a-400e-be38-623a53f01682.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2025-02-20
Reporting Person: Azelby Robert (N/A)